Copyright Reports & Markets. All rights reserved.

Global Fluoxetine Market Insights, Forecast to 2025

Buy now

Table of Contents

    Global Fluoxetine Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Fluoxetine Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Fluoxetine Market Size Growth Rate by Type
        • 1.4.2 Tablets
        • 1.4.3 Capsules
        • 1.4.4 Oral Solution
      • 1.5 Market by Application
        • 1.5.1 Global Fluoxetine Market Size Growth Rate by Application
        • 1.5.2 Depression
        • 1.5.3 Obsessive–compulsive disorder
        • 1.5.4 Panic disorder
        • 1.5.5 Bulimia nervosa
        • 1.5.6 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Fluoxetine Production
        • 2.1.1 Global Fluoxetine Revenue 2014-2025
        • 2.1.2 Global Fluoxetine Production 2014-2025
        • 2.1.3 Global Fluoxetine Capacity 2014-2025
        • 2.1.4 Global Fluoxetine Marketing Pricing and Trends
      • 2.2 Fluoxetine Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Fluoxetine Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Fluoxetine Production by Manufacturers
        • 3.1.1 Fluoxetine Production by Manufacturers
        • 3.1.2 Fluoxetine Production Market Share by Manufacturers
      • 3.2 Fluoxetine Revenue by Manufacturers
        • 3.2.1 Fluoxetine Revenue by Manufacturers (2014-2019)
        • 3.2.2 Fluoxetine Revenue Share by Manufacturers (2014-2019)
      • 3.3 Fluoxetine Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Fluoxetine Production by Regions

      • 4.1 Global Fluoxetine Production by Regions
        • 4.1.1 Global Fluoxetine Production Market Share by Regions
        • 4.1.2 Global Fluoxetine Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Fluoxetine Production
        • 4.2.2 United States Fluoxetine Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Fluoxetine Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Fluoxetine Production
        • 4.3.2 Europe Fluoxetine Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Fluoxetine Import & Export
      • 4.4 China
        • 4.4.1 China Fluoxetine Production
        • 4.4.2 China Fluoxetine Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Fluoxetine Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Fluoxetine Production
        • 4.5.2 Japan Fluoxetine Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Fluoxetine Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Fluoxetine Consumption by Regions

      • 5.1 Global Fluoxetine Consumption by Regions
        • 5.1.1 Global Fluoxetine Consumption by Regions
        • 5.1.2 Global Fluoxetine Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Fluoxetine Consumption by Application
        • 5.2.2 North America Fluoxetine Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Fluoxetine Consumption by Application
        • 5.3.2 Europe Fluoxetine Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Fluoxetine Consumption by Application
        • 5.4.2 Asia Pacific Fluoxetine Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Fluoxetine Consumption by Application
        • 5.5.2 Central & South America Fluoxetine Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Fluoxetine Consumption by Application
        • 5.6.2 Middle East and Africa Fluoxetine Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Fluoxetine Breakdown Dada by Type
      • 6.2 Global Fluoxetine Revenue by Type
      • 6.3 Fluoxetine Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Fluoxetine Breakdown Dada by Application
        • 7.2.1 Global Fluoxetine Consumption by Application
        • 7.2.2 Global Fluoxetine Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Teva
        • 8.1.1 Teva Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Fluoxetine
        • 8.1.4 Fluoxetine Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Sun Pharmaceutical
        • 8.2.1 Sun Pharmaceutical Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Fluoxetine
        • 8.2.4 Fluoxetine Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Sandoz
        • 8.3.1 Sandoz Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Fluoxetine
        • 8.3.4 Fluoxetine Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Mylan
        • 8.4.1 Mylan Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Fluoxetine
        • 8.4.4 Fluoxetine Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Wockhardt
        • 8.5.1 Wockhardt Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Fluoxetine
        • 8.5.4 Fluoxetine Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Dr.Reddy's Laboratories
        • 8.6.1 Dr.Reddy's Laboratories Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Fluoxetine
        • 8.6.4 Fluoxetine Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Pharmaceutical Associates Inc.
        • 8.7.1 Pharmaceutical Associates Inc. Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Fluoxetine
        • 8.7.4 Fluoxetine Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Lannett Company
        • 8.8.1 Lannett Company Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Fluoxetine
        • 8.8.4 Fluoxetine Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Aurobindo Pharma
        • 8.9.1 Aurobindo Pharma Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Fluoxetine
        • 8.9.4 Fluoxetine Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Alembic Pharmaceuticals
        • 8.10.1 Alembic Pharmaceuticals Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Fluoxetine
        • 8.10.4 Fluoxetine Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 Alvogen
      • 8.12 Torrent Pharmaceuticals
      • 8.13 Suzhou YUSHI Pharmaceutical
      • 8.14 Changzhou Siyao Pharmaceutical

      9 Production Forecasts

      • 9.1 Fluoxetine Production and Revenue Forecast
        • 9.1.1 Global Fluoxetine Production Forecast 2019-2025
        • 9.1.2 Global Fluoxetine Revenue Forecast 2019-2025
      • 9.2 Fluoxetine Production and Revenue Forecast by Regions
        • 9.2.1 Global Fluoxetine Revenue Forecast by Regions
        • 9.2.2 Global Fluoxetine Production Forecast by Regions
      • 9.3 Fluoxetine Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Fluoxetine Production Forecast by Type
        • 9.4.2 Global Fluoxetine Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Fluoxetine Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Fluoxetine Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Fluoxetine Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Fluoxetine Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Fluoxetine Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Fluoxetine Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Fluoxetine Upstream Market
        • 11.1.1 Fluoxetine Key Raw Material
        • 11.1.2 Typical Suppliers of Key Fluoxetine Raw Material
        • 11.1.3 Fluoxetine Raw Material Market Concentration Rate
      • 11.2 Fluoxetine Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Fluoxetine Distributors
      • 11.5 Fluoxetine Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
        Global Fluoxetine market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fluoxetine.

        This report researches the worldwide Fluoxetine market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Fluoxetine breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Teva
        Sun Pharmaceutical
        Sandoz
        Mylan
        Wockhardt
        Dr.Reddy's Laboratories
        Pharmaceutical Associates Inc.
        Lannett Company
        Aurobindo Pharma
        Alembic Pharmaceuticals
        Alvogen
        Torrent Pharmaceuticals
        Suzhou YUSHI Pharmaceutical
        Changzhou Siyao Pharmaceutical

        Fluoxetine Breakdown Data by Type
        Tablets
        Capsules
        Oral Solution
        Fluoxetine Breakdown Data by Application
        Depression
        Obsessive–compulsive disorder
        Panic disorder
        Bulimia nervosa
        Others

        Fluoxetine Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Fluoxetine Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Fluoxetine capacity, production, value, consumption, status and forecast;
        To focus on the key Fluoxetine manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Fluoxetine :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now